In the highly regulated environment of clinical research, maintaining objective oversight is critical to ensuring data integrity, patient safety, and regulatory approval. To support this imperative, Protheragen offers comprehensive Third-Party Audits. As an independent entity, we provide objective evaluations of your clinical trial processes, documentation, and partner facilities to identify potential risks before they escalate into regulatory compliance issues.
Whether you are preparing for a regulatory inspection or seeking routine quality assurance oversight, our seasoned auditors possess the deep industry knowledge required to evaluate your programs.
Protheragen provides a comprehensive range of independent audit services covering key areas of clinical development. Each audit is conducted by qualified professionals following a structured methodology aligned with ICH GCP principles and applicable regulatory standards.
Evaluation of bioequivalence (BE), pharmacokinetic (PK), and Phase I studies. Audits cover protocol adherence, bioanalytical documentation, dosing procedures, sample handling, and data integrity to confirm the reliability of early-phase clinical data.
On-site or remote assessment of investigator sites. The audit verifies informed consent processes, source data documentation, investigational product accountability, adverse event reporting, and overall compliance with the study protocol and GCP.
Comprehensive review of the Trial Master File, whether paper-based or electronic (eTMF). The review examines completeness, document version control, audit trail integrity, and alignment with the ICH GCP essential documents list.
Clinical trial SOP compliance audit aims to evaluate the adequacy, implementation, and regulatory alignment of clinical trial SOP systems. Our audits focus on identifying procedural gaps, document control weaknesses, and operational inconsistencies that may affect quality management and inspection readiness.
Independent review of clinical data management systems and processes. The scope includes database design, validation, query management, and electronic data capture compliance to ensure the final dataset is reliable and uncompromised.
We conduct independent reviews of the Statistical Analysis Plan (SAP) and the underlying programming scripts. This audit ensures that the statistical methodologies applied are consistent with the protocol and that the derived datasets are accurate, preventing errors in the interpretation of primary and secondary endpoints.
The CSR is the primary document submitted to regulatory agencies. Our audit focuses on the internal consistency between the protocol, the statistical tables, and the final narrative. We ensure that all safety and efficacy findings are reported transparently and that the conclusions are supported by the presented data.
Focused audit of clinical data packages intended for submission to the NMPA. The audit checks for completeness, consistency, and adherence to specific NMPA documentation expectations to help avoid submission delays.
Evaluation of central laboratory operations that support clinical trials. The audit covers sample receipt and chain of custody, analytical method validation, equipment calibration and maintenance, internal quality control procedures, and data reporting accuracy.
Evaluate the overall quality framework of your organization, including internal quality systems, supplier and vendor oversight, and CAPA effectiveness. This service identifies critical compliance gaps and delivers objective assessments to help optimize processes, protect patient safety, and ensure data integrity.
In the complex landscape of clinical development, internal quality control is often insufficient to detect systemic blind spots. Third-party audits provide an objective perspective that complements internal quality control processes.
1. Ensuring Objective and Unbiased Evaluation
A third-party audit offers a completely neutral perspective, free from internal organizational biases. This independence ensures an objective evaluation of trial conduct based strictly on factual evidence and current regulatory standards.
2. Regulatory Readiness
Serving as a proactive "mock inspection," these audits prepare sites and sponsors for official regulatory oversight. Addressing gaps in the Trial Master File (TMF) and operational processes beforehand significantly reduces the risk of warning letters or clinical holds.
3. Enhancing Subject Safety and Data Integrity
Independent audits systematically verify informed consent procedures, safety reporting, and data management. This rigorous oversight ensures the protection of trial participants' rights and confirms that the final clinical data are accurate and reliable.
To learn more about our third-party audit services or to request a proposal tailored to your needs, please feel free to contact us. We are available to answer your questions, discuss timelines, and provide detailed information on how Protheragen can support the quality and compliance of your clinical research programs.
1. What is a third-party clinical trial audit?
A third-party clinical trial audit is an independent, systematic examination of trial-related activities and documents conducted by an organization not directly involved in the study. It evaluates compliance with the protocol, GCP, standard operating procedures, and applicable regulatory requirements.
2. When is the best time to schedule a clinical trial audit?
Audits can be valuable at multiple points: during early recruitment to identify systemic issues before they affect the dataset, before database lock to confirm data quality, as a pre-submission check before regulatory filing, or as part of an ongoing routine quality assurance program. The optimal timing depends on the study's risk profile and objectives.
3. What qualifications do Protheragen auditors have?
Protheragen auditors possess backgrounds in clinical research, quality assurance, or regulatory affairs. They maintain thorough knowledge of GCP, applicable international and regional regulations, and contemporary auditing techniques. Auditors operate independently to preserve objectivity.
4. Can these clinical trial audits be conducted remotely?
Yes. While on-site audits are recommended for investigative site and laboratory evaluations to observe physical facilities, many audits can be effectively conducted remotely. TMF audits, data management audits, and statistical analysis audits are routinely performed off-site using secure electronic systems.